ASLAN Pharmaceuticals (ASLN) Announces New Translational Data on Eblasakimab

Go back to ASLAN Pharmaceuticals (ASLN) Announces New Translational Data on Eblasakimab
(NASDAQ: ASLN) Delayed: 0.60 --0 (-0%)
Previous Close $0.60    52 Week High $ 
Open $0.60    52 Week Low $ 
Day High $0.60    P/E N/A 
Day Low $0.60    EPS $ 
Volume 171,527